Medivir AB (publ) (Nasdaq Stockholm) has resolved on a voluntary share redemption programme of SEK 625 million. Vinge advises Medivir. The Vinge team primarily consists of Erik Sjöman (partner, capital markets & public M&A) and Rikard Lindahl.